Healthcare

In its 27 October 2026 report for the quarter ended 30 September, Oneview said it signed initial Bedside Hub TV agreements with Albany Med Health System, Baptist Health, Jupiter Medical Center and Shannon Health, which together have almost 5,000 beds. The signed agreements cover …

Oneview Healthcare shares traded at $0.145, up 20.83%, during the session. Oneview reported six new customers, including four initial Bedside Hub TV agreements, and cash of €2.4 million at 30 September 2026 in its Appendix 4C dated 27 October 2026. The announcement is dated …

The SAPPHIRE study, registered as ALA-101-001, is an open-label, multi-centre, dose-escalation and expansion trial. It will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of a single dose of ALA-101 in patients with relapsed or refractory CD19-positive non-Hodgkin lymphoma and leukaemia.

Oneview signed initial Bedside Hub TV agreements with Albany Med Health System, Baptist Health, Jupiter Medical Center and Shannon Health. Bedside Hub, launched in May 2026, provides healthcare-grade hardware and cloud-based device management to host Epic MyChart Bedside TV. The four organisations have a …

The agreement covers four genotypes, MXC-THC-10/3, MXC-THC-81/5, MXC-THC-40/3 and MXC-THC-40/2. TPI receives exclusive worldwide rights to cultivate, propagate, process, extract, manufacture, market, distribute, import and export the licensed genetics and products derived from them, including flower, extracts and cannabinoid active pharmaceutical ingredients, subject to …

The company said GPs can now order its ColoSTAT blood test from within MedicalDirector, one of the most widely used GP software systems in Australia. The 4Cyte Pathology blood collection network passed 100 sites across the eastern states, and the Access Program, designed to …

Across patients receiving treatment, estimated glomerular filtration rate, or eGFR, improved significantly from Week 26 through trial completion. Mean eGFR increased by 7.2 mL/min/1.73 m² at Week 26 and by 9.6 at Week 52. At the one-year mark, 68.9% of patients recorded an increase …